Ademola Olabode Ayeleso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ademola Olabode Ayeleso has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Monde Ntwasa
Department of Life and Consumer Sciences, University of South Africa, Johannesburg, South Africa
3 shared publications - Emmanuel Mukwevho
Department of Biochemistry, North West University, Private Bag X2046, Mmabatho 2735, South Africa
2 shared publications - Oluwafemi Omoniyi Oguntibeju
Phytomedicine and Phytochemistry Group, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences Cape Peninsula University of Technology Bellville South Africa
2 shared publications - Sogolo Lucky Lebelo
Department of Life and Consumer Sciences, University of South Africa, Johannesburg 1709, South Africa
2 shared publications Adeshina I. Odugbemi
Biochemistry Programme College of Agriculture, Engineering and Sciences Bowen University Iwo Nigeria
1 shared publicationAdetoun Morakinyo
Department of Biochemistry, Faculty of Science, Adeleke University, Ede 232101, Osun State, Nigeria
1 shared publication
Latest Publications
- Open Access
- 14 February 2026
- Published by MDPI AG in Applied Biosciences
- Vol. 5 (1) , 13
Computational Approach to Possible Interactions of Gliclazide with Proteins of Inflammatory, Oxidative Stress and Endoplasmic Reticulum Stress Pathways
The present study aims to evaluate the interaction of gliclazide with proteins related to inflammation—{inhibitor of nuclear factor kappa-B kinase subunit beta (IKKα) and NF-kappa-B-inducing kinase (NIK)}; oxidative stress—{kelch domain of Kelch-like ECH-associated protein 1 (KKeap1)} and ER stress—{inositol-requiring enzyme-1alpha (IRE1α)}. X-ray crystal structure of IKKα, (PDB ID: 5EBZ), KKeap1 (PDB ID: 4L7B), NIK (PDB ID: 8YHW) and IRE1α (PDB ID: 4YZ9) were obtained from Protein Data Bank and Open Babel 3.1.1 was used to prepare the ligands. Prior to docking, protein structures were prepared by removing water molecules, adding hydrogen atoms, and optimizing side chain conformations using Maestro (Schrödinger Suite, version 2024-2) along with the OPLS4 force field. Ligand docking was performed using the Glide application. Molecular dynamics simulation was performed with Desmond (Schrödinger Suite) within the Maestro interface for 100 ns for the NPT ensemble at 300 K and 1 atm pressure. Physicochemical and pharmacokinetics properties were analyzed using ADMETlab 3.0 and SwissADME. The binding energies of gliclazide with IKKα, NIK, KKeap1 and IRE1α were −8.3, −7.9, −8.4 and −8.8, respectively. Root mean square displacement (RMSD), root mean square fluctuation (RMSF) and radius of gyration analyses predicted relatively strong and stable interactions between gliclazide and the proteins, with favourable pharmacokinetic properties. It was also observed that CYP3A4 metabolizes gliclazide, in addition to CYP2C9 and CYP2C19. The activity of gliclazide against inflammation, oxidative stress and endoplasmic reticulum stress might be via interaction with these proteins.
- 14 February 2026
- Published by MDPI AG in Applied Biosciences
- Vol. 5 (1) , 13
Open AccessComputational Approach to Possible Interactions of Gliclazide with Proteins of Inflammatory, Oxidative Stress and Endoplasmic Reticulum Stress Pathways
The present study aims to evaluate the interaction of gliclazide with proteins related to inflammation—{inhibitor of nuclear factor kappa-B kinase subunit beta (IKKα) and NF-kappa-B-inducing kinase (NIK)}; oxidative stress—{kelch domain of Kelch-like ECH-associated protein 1 (KKeap1)} and ER stress—{inositol-requiring enzyme-1alpha (IRE1α)}. X-ray crystal structure of IKKα, (PDB ID: 5EBZ), KKeap1 (PDB ID: 4L7B), NIK (PDB ID: 8YHW) and IRE1α (PDB ID: 4YZ9) were obtained from Protein Data Bank and Open Babel 3.1.1 was used to prepare the ligands. Prior to docking, protein structures were prepared by removing water molecules, adding hydrogen atoms, and optimizing side chain conformations using Maestro (Schrödinger Suite, version 2024-2) along with the OPLS4 force field. Ligand docking was performed using the Glide application. Molecular dynamics simulation was performed with Desmond (Schrödinger Suite) within the Maestro interface for 100 ns for the NPT ensemble at 300 K and 1 atm pressure. Physicochemical and pharmacokinetics properties were analyzed using ADMETlab 3.0 and SwissADME. The binding energies of gliclazide with IKKα, NIK, KKeap1 and IRE1α were −8.3, −7.9, −8.4 and −8.8, respectively. Root mean square displacement (RMSD), root mean square fluctuation (RMSF) and radius of gyration analyses predicted relatively strong and stable interactions between gliclazide and the proteins, with favourable pharmacokinetic properties. It was also observed that CYP3A4 metabolizes gliclazide, in addition to CYP2C9 and CYP2C19. The activity of gliclazide against inflammation, oxidative stress and endoplasmic reticulum stress might be via interaction with these proteins.
- Open Access
- 31 December 2025
- Published by University of Benin in Tropical Journal of Natural Product Research
- Vol. 9 (12) , 6403-6412
ERRATUM: Impact of some Bioactive Compounds of Flavonoid-Rich Fraction of Monodora tenuifolia, Benth on Glucose Concentration and Certain Proteins Associated with Glucose Metabolism using Molecular Docking Approach
Hyperglycemia is a hallmark of diabetes mellitus, known to be a metabolic disorder caused by excess blood glucose due to lack of insulin secretion, or cellular insensitivity to insulin or damage to pancreatic β-cell. This study focused on the potential of flavonoid-rich fraction of M. tenuifolia seeds (FRFMTS) to reducing plasma glucose concentration in diabetic rats and determine the molecular interaction of some phytochemicals in FRRMTS against certain proteins associated with diabetes mellitus. The plant sample was pulverized and extracted at 1g in 5 ml of 80% v/v ethanol to obtain hydro-ethanol extract subjected to solvent-solvent fractionation to obtain the FRFMTS used for HPLC screening. Seven (7) groups of male Wistar rats containing six (6) rats each were used. The groups were normal control, 25 mg/kg FRFMTS, 50 mg/kg FRFMTS, diabetic control, diabetic rats + 25 mg/kg FRFMTS, diabetic rats + 50 mg/kg FRFMTS and diabetic rats + metformin (6.67 mg/kg). A glucose oxidase kit was used to determine blood glucose concentrations, while the molecular interactions with some target proteins were docked using the extra precision (XP) algorithm. The results revealed a significant increase in the plasma glucose of diabetic control group in comparison to normal control group. Diabetic rats treated with 25 mg/kg FRFMTS, 50 mg/kg FRFMTS and metformin showed that glucose concentrations significantly reduced compared to diabetic control group. The molecular docking model revealed highest binding affinity of quercetin to acetyl-CoA carboxylase, glucose-1-transporter, glycogen synthase kinase 3β, glucagon-like peptide 1 and insulin receptor kinase. This study suggests that FRFMTS possesses glucose lowering ability and quercetin present in FRFMTS binds effectively to proteins linked to diabetes and could elicit antihyperglycemic effect.
- 31 December 2025
- Published by University of Benin in Tropical Journal of Natural Product Research
- Vol. 9 (12) , 6403-6412
Open AccessERRATUM: Impact of some Bioactive Compounds of Flavonoid-Rich Fraction of Monodora tenuifolia, Benth on Glucose Concentration and Certain Proteins Associated with Glucose Metabolism using Molecular Docking Approach
Hyperglycemia is a hallmark of diabetes mellitus, known to be a metabolic disorder caused by excess blood glucose due to lack of insulin secretion, or cellular insensitivity to insulin or damage to pancreatic β-cell. This study focused on the potential of flavonoid-rich fraction of M. tenuifolia seeds (FRFMTS) to reducing plasma glucose concentration in diabetic rats and determine the molecular interaction of some phytochemicals in FRRMTS against certain proteins associated with diabetes mellitus. The plant sample was pulverized and extracted at 1g in 5 ml of 80% v/v ethanol to obtain hydro-ethanol extract subjected to solvent-solvent fractionation to obtain the FRFMTS used for HPLC screening. Seven (7) groups of male Wistar rats containing six (6) rats each were used. The groups were normal control, 25 mg/kg FRFMTS, 50 mg/kg FRFMTS, diabetic control, diabetic rats + 25 mg/kg FRFMTS, diabetic rats + 50 mg/kg FRFMTS and diabetic rats + metformin (6.67 mg/kg). A glucose oxidase kit was used to determine blood glucose concentrations, while the molecular interactions with some target proteins were docked using the extra precision (XP) algorithm. The results revealed a significant increase in the plasma glucose of diabetic control group in comparison to normal control group. Diabetic rats treated with 25 mg/kg FRFMTS, 50 mg/kg FRFMTS and metformin showed that glucose concentrations significantly reduced compared to diabetic control group. The molecular docking model revealed highest binding affinity of quercetin to acetyl-CoA carboxylase, glucose-1-transporter, glycogen synthase kinase 3β, glucagon-like peptide 1 and insulin receptor kinase. This study suggests that FRFMTS possesses glucose lowering ability and quercetin present in FRFMTS binds effectively to proteins linked to diabetes and could elicit antihyperglycemic effect.
- Open Access
- 11 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7762
Eggplant (Solanum spp.) Fruits Dietary Polyphenols Upregulate the Expression of Glucose Transporter Protein in Palmitate-Induced Diabetic Cell Line C2C12
Studies utilizing cell-based systems to investigate plant-based diets for diabetes management are gaining attention due to the adverse effects associated with commercially available drugs. However, the molecular mechanisms underlying the anti-diabetic effects of specific plant-derived products remain inadequately explored. The major aim of our study was to elucidate the molecular mechanisms by which bioactive compounds in the fruit of Solanum spp. influence key proteins associated with type 2 diabetes. The expressions of genes such as glucose transporter protein 4 (GLUT4), myocyte enhancer factor-2 (MEF-2A), and nuclear respiratory factor-1 (NRF-1) were investigated in a palmitate-induced C2C12 cell model of type 2 diabetes mellitus. The structures of these proteins were retrieved from the protein database, while bioactive compounds previously identified in Solanum spp. were obtained from PubChem site. Drug-likeness properties of these compounds (ligands) were assessed. The docked protein-ligand complexes were further analyzed using the Protein-Ligand Profiler web server. Our results showed that the studied compounds from Solanum spp. profoundly upregulated GLUT4 expression (9–19-fold increase) in the C2C12 cell line, thus surpassing the effects of the standard anti-diabetic drug metformin. Additionally, activities of antioxidant enzymes catalase, superoxide dismutase, and glutathione peroxidase were elevated. Molecular docking showed that rutin, an abundant flavonoid from Solanum spp., had the highest binding affinity for the active sites of the target proteins. These findings provide new mechanistic insight into the anti-diabetic effects of Solanum spp., primarily due to its high rutin content, which plays a major role in the plant’s glucose-regulating and antioxidant actions. Our findings underscore the potential use of Solanum spp. as an affordable functional food for managing type 2 diabetes, especially in developing countries with limited resources for purchasing drugs. Although promising, our findings should be further validated by clinical studies.
- 11 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7762
Open AccessEggplant (Solanum spp.) Fruits Dietary Polyphenols Upregulate the Expression of Glucose Transporter Protein in Palmitate-Induced Diabetic Cell Line C2C12
Studies utilizing cell-based systems to investigate plant-based diets for diabetes management are gaining attention due to the adverse effects associated with commercially available drugs. However, the molecular mechanisms underlying the anti-diabetic effects of specific plant-derived products remain inadequately explored. The major aim of our study was to elucidate the molecular mechanisms by which bioactive compounds in the fruit of Solanum spp. influence key proteins associated with type 2 diabetes. The expressions of genes such as glucose transporter protein 4 (GLUT4), myocyte enhancer factor-2 (MEF-2A), and nuclear respiratory factor-1 (NRF-1) were investigated in a palmitate-induced C2C12 cell model of type 2 diabetes mellitus. The structures of these proteins were retrieved from the protein database, while bioactive compounds previously identified in Solanum spp. were obtained from PubChem site. Drug-likeness properties of these compounds (ligands) were assessed. The docked protein-ligand complexes were further analyzed using the Protein-Ligand Profiler web server. Our results showed that the studied compounds from Solanum spp. profoundly upregulated GLUT4 expression (9–19-fold increase) in the C2C12 cell line, thus surpassing the effects of the standard anti-diabetic drug metformin. Additionally, activities of antioxidant enzymes catalase, superoxide dismutase, and glutathione peroxidase were elevated. Molecular docking showed that rutin, an abundant flavonoid from Solanum spp., had the highest binding affinity for the active sites of the target proteins. These findings provide new mechanistic insight into the anti-diabetic effects of Solanum spp., primarily due to its high rutin content, which plays a major role in the plant’s glucose-regulating and antioxidant actions. Our findings underscore the potential use of Solanum spp. as an affordable functional food for managing type 2 diabetes, especially in developing countries with limited resources for purchasing drugs. Although promising, our findings should be further validated by clinical studies.
- Open Access
- 19 December 2024
- Published by African Journals Online (AJOL) in Journal of Phytomedicine and Therapeutics
- Vol. 23 (2) , 1570-1581
In-vitro assessment of the antioxidant potentials of cyanocobalamin (vitamin B12): A comparative study with ascorbic acid
Cyanocobalamin is a form of vitamin B₁₂, which is a water-soluble vitamin that is naturally present in some foods and available as a dietary supplement as well as prescription medication to manage some illnesses. This study aimed to examine the ability of cyanocobalamin to scavenge free radicals using in vitro methods in comparison to ascorbic acid (control). Biochemical tests such as 1'1 diphenyl-2 picryl hydrazine (DPPH) radical, Ferric Reducing Antioxidant Power (FRAP), Fe2+ chelation, hydroxyl radical (OH•), nitric oxide (NO•), and inhibition of lipid peroxidation assays were carried using established procedures. The results revealed that ascorbic acid control scavenged DPPH radical (EC50 = 1.514 mM) and OH• radical (EC50 = 1.562 mM) better than cyanocobalamin (EC50 = 3.751 mM), (EC50 = 1.942 mM) while cyanocobalamin chelated Fe2+ (EC50 = 3.849 mM), scavenged NO• radical (EC50 = 1.812 mM) and also inhibited lipid peroxidation (EC50 = 1.787 mM) better than the ascorbic acid. No significant difference was observed (p < 0.05) as both the cyanocobalamin and ascorbic acid control had similar FRAP. These findings suggest that cyanocobalamin may be utilized as a supplement to manage oxidative stress- mediated diseases.
- 19 December 2024
- Published by African Journals Online (AJOL) in Journal of Phytomedicine and Therapeutics
- Vol. 23 (2) , 1570-1581
Open AccessIn-vitro assessment of the antioxidant potentials of cyanocobalamin (vitamin B12): A comparative study with ascorbic acid
Cyanocobalamin is a form of vitamin B₁₂, which is a water-soluble vitamin that is naturally present in some foods and available as a dietary supplement as well as prescription medication to manage some illnesses. This study aimed to examine the ability of cyanocobalamin to scavenge free radicals using in vitro methods in comparison to ascorbic acid (control). Biochemical tests such as 1'1 diphenyl-2 picryl hydrazine (DPPH) radical, Ferric Reducing Antioxidant Power (FRAP), Fe2+ chelation, hydroxyl radical (OH•), nitric oxide (NO•), and inhibition of lipid peroxidation assays were carried using established procedures. The results revealed that ascorbic acid control scavenged DPPH radical (EC50 = 1.514 mM) and OH• radical (EC50 = 1.562 mM) better than cyanocobalamin (EC50 = 3.751 mM), (EC50 = 1.942 mM) while cyanocobalamin chelated Fe2+ (EC50 = 3.849 mM), scavenged NO• radical (EC50 = 1.812 mM) and also inhibited lipid peroxidation (EC50 = 1.787 mM) better than the ascorbic acid. No significant difference was observed (p < 0.05) as both the cyanocobalamin and ascorbic acid control had similar FRAP. These findings suggest that cyanocobalamin may be utilized as a supplement to manage oxidative stress- mediated diseases.
- Open Access
- 1 April 2024
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 13 (2) , 216-225
Effects of hydroethanolic garlic extract on oxidative stress, lipolysis, and glycogenesis in high-fat diet-fed Drosophila melanogaster
Introduction: Metabolic syndrome is multifaceted health condition associated with metabolism, which leads to the accumulation of oxidation products and impairment of the antioxidant system. Medicinal, edible plant alternatives are being sought to prevent the predisposing factors of metabolic syndrome, one of which is obesity. We studied the effects of hydroethanolic garlic extract (HGE) on oxidative stress, lipolysis, and glycogenesis in high-fat diet-fed Drosophila melanogaster. Methods: The HGE was processed and antioxidant assays (in vitro and in vivo) coupled with metabolic biomarkers were assayed following standard procedures. Results: HGE inhibited ABTS (2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), hydroxyl, and hydrogen peroxide radicals in high-fat-fed D. melanogaster. The HGE also reduced the activity of superoxide dismutase and increased catalase activity significantly. The HGE promoted lipolysis and glycogenesis by reducing cholesterol, triglycerides, and total sugar concentrations while glycogen content was increased. Conclusion: Our results revealed that HGE improved the antioxidant defense system and promoted lipolysis and glycogenesis in metabolic deranged D. melanogaster. This suggests the therapeutic usefulness of garlic in the management of metabolic diseases.
- 1 April 2024
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 13 (2) , 216-225
Open AccessEffects of hydroethanolic garlic extract on oxidative stress, lipolysis, and glycogenesis in high-fat diet-fed Drosophila melanogaster
Introduction: Metabolic syndrome is multifaceted health condition associated with metabolism, which leads to the accumulation of oxidation products and impairment of the antioxidant system. Medicinal, edible plant alternatives are being sought to prevent the predisposing factors of metabolic syndrome, one of which is obesity. We studied the effects of hydroethanolic garlic extract (HGE) on oxidative stress, lipolysis, and glycogenesis in high-fat diet-fed Drosophila melanogaster. Methods: The HGE was processed and antioxidant assays (in vitro and in vivo) coupled with metabolic biomarkers were assayed following standard procedures. Results: HGE inhibited ABTS (2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), hydroxyl, and hydrogen peroxide radicals in high-fat-fed D. melanogaster. The HGE also reduced the activity of superoxide dismutase and increased catalase activity significantly. The HGE promoted lipolysis and glycogenesis by reducing cholesterol, triglycerides, and total sugar concentrations while glycogen content was increased. Conclusion: Our results revealed that HGE improved the antioxidant defense system and promoted lipolysis and glycogenesis in metabolic deranged D. melanogaster. This suggests the therapeutic usefulness of garlic in the management of metabolic diseases.
- Open Access
- 30 August 2023
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 10 (4) , 115-126
Health and commercial relevance of Garcinia species: Key scientometric analyses from three decades of research
Garcinia species (G. indica, G. cambogia, G. kola and G. mangostana) represent some of the most sought-after herbs globally due to their impressive medicinal qualities, hence the ever-growing interest of researchers into these plants. In this study, an extensive bibliometric analysis of the available research outputs on the widely-known Garcinia species was conducted to appraise the progress made and also highlight the future focus of research on the plants. The published articles (original and conference articles) on the selected species from 1991 to 2021 were retrieved from Scopus® database, scrutinized and further analyzed using the VOS viewer software. Over 2000 research outputs were published posting an annual publication rate of 75 articles, which have altogether garnered almost 37000 citations within the period under review. Of the 85 country affiliations on the publications, 5, which include India, Thailand, Nigeria, Indonesia, and the United States have cumulatively contributed two-thirds of the total outputs. The institutions; the University of Ibadan (97), Prince Songkla University (52) and Mahidol University (50) have the most publications revealing their research focus on herbs. However, in terms of individual influence, Prof E.O. Farombi, of the University of Ibadan, led the pack with an impressive 42 publications (1585 citations) on Garcinia kola followed by Prof Y.W. Chin of the Seoul National University, South Korea with 23 publications (452 citations) on Garcinia mangostana. The versatility in the health applications of these species especially as sources for new therapeutics, nutraceuticals or functional food ingredients, has been the main driver of the research within the past three decades. Recent research undertakings have demonstrated the potential industrial uses of herbs in the clothing and petroleum industries and these may dominate the research emphases in the immediate future.
- 30 August 2023
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 10 (4) , 115-126
Open AccessHealth and commercial relevance of Garcinia species: Key scientometric analyses from three decades of research
Garcinia species (G. indica, G. cambogia, G. kola and G. mangostana) represent some of the most sought-after herbs globally due to their impressive medicinal qualities, hence the ever-growing interest of researchers into these plants. In this study, an extensive bibliometric analysis of the available research outputs on the widely-known Garcinia species was conducted to appraise the progress made and also highlight the future focus of research on the plants. The published articles (original and conference articles) on the selected species from 1991 to 2021 were retrieved from Scopus® database, scrutinized and further analyzed using the VOS viewer software. Over 2000 research outputs were published posting an annual publication rate of 75 articles, which have altogether garnered almost 37000 citations within the period under review. Of the 85 country affiliations on the publications, 5, which include India, Thailand, Nigeria, Indonesia, and the United States have cumulatively contributed two-thirds of the total outputs. The institutions; the University of Ibadan (97), Prince Songkla University (52) and Mahidol University (50) have the most publications revealing their research focus on herbs. However, in terms of individual influence, Prof E.O. Farombi, of the University of Ibadan, led the pack with an impressive 42 publications (1585 citations) on Garcinia kola followed by Prof Y.W. Chin of the Seoul National University, South Korea with 23 publications (452 citations) on Garcinia mangostana. The versatility in the health applications of these species especially as sources for new therapeutics, nutraceuticals or functional food ingredients, has been the main driver of the research within the past three decades. Recent research undertakings have demonstrated the potential industrial uses of herbs in the clothing and petroleum industries and these may dominate the research emphases in the immediate future.
- 11 April 2023
- Published by Taylor & Francis
- p. 293-315
Antioxidant, Anti-Inflammatory, and Thrombolytic Activities of Monodora tenuifolia, Benth Seed Extract
In this study, in vitro antioxidant, anti-inflammatory, and thrombolytic activities of Monodora tenuifolia Benth seed extract were explored. The procedure involved identification, collection, authentication, and extraction of M. tenuifolia seed extract with 80% (v/v) ethanol. The evaluation of antioxidant capacity (DPPH, FRAP, H2O2, and ABTS) of the extract was done using established protocols. The anti-inflammatory as well as thrombolytic activities of the extract were also investigated with standard methods. Results obtained showed that alkaloids, flavonoids, tannins, and proteins were present in the extract while saponin was absent. Quantitatively, the extract contained total phenolic 21.43 ± 0.03 mg/g extract (TAE), flavonoid 190.40 ± 2.52 QE/g, Vitamin C content was 40.60 ± 0.60 mg/g, and vitamin E content was 14.20 ± 0.04 mg/g QE and protein 6.80 ± 0.01 mg/g. Moreover, extract exhibited anti-inflammatory potential by inhibiting albumin denaturation in all the different concentrations used in the study. The extract also showed appreciable thrombolytic activities in concentration-dependent manner but not as effective as the standard drug. Even though the extract showed antioxidant potentials, these activities were significantly lower than the standard drugs used. Summarily, the study indicated that M. tenuifolia seeds contain bioactive compounds with anti-inflammatory and thrombolytic effects.
- 11 April 2023
- Published by Taylor & Francis
- p. 293-315
Antioxidant, Anti-Inflammatory, and Thrombolytic Activities of Monodora tenuifolia, Benth Seed Extract
In this study, in vitro antioxidant, anti-inflammatory, and thrombolytic activities of Monodora tenuifolia Benth seed extract were explored. The procedure involved identification, collection, authentication, and extraction of M. tenuifolia seed extract with 80% (v/v) ethanol. The evaluation of antioxidant capacity (DPPH, FRAP, H2O2, and ABTS) of the extract was done using established protocols. The anti-inflammatory as well as thrombolytic activities of the extract were also investigated with standard methods. Results obtained showed that alkaloids, flavonoids, tannins, and proteins were present in the extract while saponin was absent. Quantitatively, the extract contained total phenolic 21.43 ± 0.03 mg/g extract (TAE), flavonoid 190.40 ± 2.52 QE/g, Vitamin C content was 40.60 ± 0.60 mg/g, and vitamin E content was 14.20 ± 0.04 mg/g QE and protein 6.80 ± 0.01 mg/g. Moreover, extract exhibited anti-inflammatory potential by inhibiting albumin denaturation in all the different concentrations used in the study. The extract also showed appreciable thrombolytic activities in concentration-dependent manner but not as effective as the standard drug. Even though the extract showed antioxidant potentials, these activities were significantly lower than the standard drugs used. Summarily, the study indicated that M. tenuifolia seeds contain bioactive compounds with anti-inflammatory and thrombolytic effects.
- Open Access
- 16 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 292
Influence of Flavonoid-Rich Fraction of Monodora tenuifolia Seed Extract on Blood Biochemical Parameters in Streptozotocin-Induced Diabetes Mellitus in Male Wistar Rats
Diabetes mellitus is a metabolic disorder caused by either the total destruction of the pancreatic beta cells that secrete insulin for the uptake of glucose from the circulation or as a result of the inability of body cells to respond to the presence of insulin in the blood. The present study investigated the effect of a flavonoid-rich fraction of Monodora tenuifolia seed extract (FFMTSE) on blood parameters in streptozotocin (STZ)-induced diabetic male Wistar rats. The rats were divided into seven groups (n = 6). Group 1: normal control rats, Group 2: rats + FFMTSE (25 mg/kgbwt), Group 3: rats + FFMTSE (50 mg/kgbwt), Group 4: diabetic control rats, Group 5: diabetic rats + FFMTSE (25 mg/kgbwt), Group 6: diabetic rats + FFMTSE (50 mg/kgbwt), and Group 7: diabetic rats + Metformin. The assessment of the lipid profile, kidney functions (urea and creatinine), and cardiac biomarkers (LDH and CK-MB) were carried out in the plasma using established protocols. The results showed a significant increase in the concentrations of triacylglycerol, cholesterol, LDL-cholesterol, VLDL-cholesterol, urea, and creatinine, as well as in cardiac enzyme activities in diabetic rats. However, the administration of the FFMTSE significantly improved the observed biochemical parameters. In addition, an increased concentration of HDL-cholesterol concentration was observed in the diabetic rats upon treatment with FFMTSE. These findings indicate that FFMTSE could be a potent anti-nephropathy and anti-cardiomyopathy agent in diabetic conditions.
- 16 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 292
Open AccessInfluence of Flavonoid-Rich Fraction of Monodora tenuifolia Seed Extract on Blood Biochemical Parameters in Streptozotocin-Induced Diabetes Mellitus in Male Wistar Rats
Diabetes mellitus is a metabolic disorder caused by either the total destruction of the pancreatic beta cells that secrete insulin for the uptake of glucose from the circulation or as a result of the inability of body cells to respond to the presence of insulin in the blood. The present study investigated the effect of a flavonoid-rich fraction of Monodora tenuifolia seed extract (FFMTSE) on blood parameters in streptozotocin (STZ)-induced diabetic male Wistar rats. The rats were divided into seven groups (n = 6). Group 1: normal control rats, Group 2: rats + FFMTSE (25 mg/kgbwt), Group 3: rats + FFMTSE (50 mg/kgbwt), Group 4: diabetic control rats, Group 5: diabetic rats + FFMTSE (25 mg/kgbwt), Group 6: diabetic rats + FFMTSE (50 mg/kgbwt), and Group 7: diabetic rats + Metformin. The assessment of the lipid profile, kidney functions (urea and creatinine), and cardiac biomarkers (LDH and CK-MB) were carried out in the plasma using established protocols. The results showed a significant increase in the concentrations of triacylglycerol, cholesterol, LDL-cholesterol, VLDL-cholesterol, urea, and creatinine, as well as in cardiac enzyme activities in diabetic rats. However, the administration of the FFMTSE significantly improved the observed biochemical parameters. In addition, an increased concentration of HDL-cholesterol concentration was observed in the diabetic rats upon treatment with FFMTSE. These findings indicate that FFMTSE could be a potent anti-nephropathy and anti-cardiomyopathy agent in diabetic conditions.
- Open Access
- 30 March 2020
- Published by SAGE Publications in Natural Product Communications
- Vol. 15 (3)
Potential Protective Effects of Neonatal Supplementation with Oleanolic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)-Ligand Dependent Regulation of Glucose Homeostasis in High Fructose-Fed Rats
The effect of neonatal oral supplementation of oleanolic acid (OA) on peroxisome proliferator-activated receptor gamma (PPARγ)-1 on glucose homeostasis in high fructose-fed rats was investigated. Rat pups (7 days old) were randomly assigned to and randomly administered with control (Distilled water, DW), OA (60 mg/kg), metformin (MET, 500 mg/kg), high fructose solution (HFS, 20% w/v), OA + HFS, MET + HFS, and treated till postnatal day (PND) 14. The pups were weaned onto a standard diet on PND 21 up to PND 111 and terminated on PND 112. Glucose derivatives and gene expressions of PPARγ-1 and glucose transporter type 4 (Glut-4) in the skeletal muscles were determined by using reverse transcription-quantitative polymerase chain reaction and gas chromatography-mass spectrometry, respectively. HFS significantly lowered glucose concentration and showed the propensity to suppress the expression of PPARγ-1, but not significantly. OA and MET alone significantly increased PPARγ-1 and Glut-4 expressions. There was no significant difference between the OA and OA + HFS for PPARγ-1 and Glut-4 expressions, although OA expressions were always higher than that of the OA + HFS group. An elevated level of glucose-6-phosphate was observed in OA, MET, and OA + HFS groups. Ribose-5-phosphate was significantly higher in OA and MET groups than the control. Ribose-5-phosphate was also significantly high in OA-treated group compared with OA + HFS. It is concluded that the neonatal supplementation with OA could help to improve the activity of PPARγ in reducing the burden of metabolic diseases.
- 30 March 2020
- Published by SAGE Publications in Natural Product Communications
- Vol. 15 (3)
Open AccessPotential Protective Effects of Neonatal Supplementation with Oleanolic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)-Ligand Dependent Regulation of Glucose Homeostasis in High Fructose-Fed Rats
The effect of neonatal oral supplementation of oleanolic acid (OA) on peroxisome proliferator-activated receptor gamma (PPARγ)-1 on glucose homeostasis in high fructose-fed rats was investigated. Rat pups (7 days old) were randomly assigned to and randomly administered with control (Distilled water, DW), OA (60 mg/kg), metformin (MET, 500 mg/kg), high fructose solution (HFS, 20% w/v), OA + HFS, MET + HFS, and treated till postnatal day (PND) 14. The pups were weaned onto a standard diet on PND 21 up to PND 111 and terminated on PND 112. Glucose derivatives and gene expressions of PPARγ-1 and glucose transporter type 4 (Glut-4) in the skeletal muscles were determined by using reverse transcription-quantitative polymerase chain reaction and gas chromatography-mass spectrometry, respectively. HFS significantly lowered glucose concentration and showed the propensity to suppress the expression of PPARγ-1, but not significantly. OA and MET alone significantly increased PPARγ-1 and Glut-4 expressions. There was no significant difference between the OA and OA + HFS for PPARγ-1 and Glut-4 expressions, although OA expressions were always higher than that of the OA + HFS group. An elevated level of glucose-6-phosphate was observed in OA, MET, and OA + HFS groups. Ribose-5-phosphate was significantly higher in OA and MET groups than the control. Ribose-5-phosphate was also significantly high in OA-treated group compared with OA + HFS. It is concluded that the neonatal supplementation with OA could help to improve the activity of PPARγ in reducing the burden of metabolic diseases.